Our Blog

To Our Community: The world is facing an extraordinary challenge with the spread of COVID-19. Like you, we’re deeply concerned and will do what we can to help keep our teams, communities, and families safe and healthy.  We’re closely monitoring the spread of the virus and how it may affect our employees and business operations. […]

Our CEO, Rob Davidson sat down for a chat with Cannabis Radio to discuss the particular advantages of our oral thin film, CUREfilm®  and the benefits of our technology in the delivery of cannabinoid molecules.   Listen to “Innovative Drug Delivery And Development” on Spreaker.  This interview was originally published on Oct 1, 2019 on CannabisRadio.com Audio Transcript […]

The Pacific Coast Business Times recently announced the 15 Fastest-Growing Companies for 2019 and CURE Pharmaceutical came in at the top spot with a 510 percent three-year revenue growth. The complete list of 15 companies in the Tri-County area is below. The Tri-County Area includes the counties of San Luis Obispo, Santa Barbara, and Ventura. […]

This podcast and transcript are republished with permission from PharmaVoice.  ————– Welcome to WoW, the Woman of the Week podcast series by PharmaVOICE. This episode was made possible by a generous sponsorship from Micromass.  In this episode, Taren Grom, Editor-In-Chief of PharmaVOICE magazine meets with Jessica Rousset, Chief Operating Officer, Cure Pharmaceutical.  Taren: Jessica, welcome […]

On Monday, April 1, we announced our plans to acquire Chemistry Holdings, a formulation technology company that is developing innovative delivery systems for the nutraceutical and pharmaceutical industry. An Expansion of Our PlatformWith this acquisition, we expect to expand our platform of oral dosage forms beyond dissolving films. We will also seek to combine proprietary encapsulation […]

The 2018 Farm Bill, which was passed by Congress and signed by President Donald Trump today, is a large, multifaceted piece of legislation outlining regulations on everything from food stamps to environmental land use. Renewed roughly every five years, the farm bill sets policies and reauthorizes farm, nutrition, rural development, conservation, agricultural trade, and other […]

CURE Pharma open to US CRO contract in February 2019 for PK/bioavailability study for thin film sildenafil, updates NASDAQ up-listing and partnering plans, CEO says CURE Pharmaceuticals (OTC:CURR) welcomes CRO approaches in February 2019 for a pharmacokinetic/bioavailability study of its thin film formulation of sildenafil for erectile dysfunction, said CEO Robert Davidson. Once the Oxnard, […]

In this third and final installment of our blog series on cannabinoids, we examine the current legal status of cannabis and products derived from the plant. Click to read the other articles in this series: The Role of the Endocannabinoid System in the Human Body and Exploring the Entourage Effect.With Canada poised to legalize marijuana […]

  Our partner, Sleep Club just launched a new product, Sleep Stripzzz – an innovative sleep and recovery aid powered by our CUREfilm technology. It contains a soothing blend of melatonin, naturally occurring amino acids and beneficial vitamins that promote balanced sleep patterns. Read the official press release here.      

Our COO Jessica Rousset did a quick interview with Proactive Investors last week. She discussed the CURE Pharmaceutical licensing deal with Canopy Growth Corp where Canopy will have an exclusive license to our patented, multi-layer oral thin film technology for use with cannabis extracts and biosynthetic cannabinoids.The license agreement allows CURE to accelerate and expand […]

THC and CBD are the most widely researched cannabinoids in cannabis science. However, the reality is that both compounds are only part of the story. THC and CBD, along with at least other 113 other cannabinoids, operate in sync with hundreds of other compounds to modulate cannabis’s psychotropic and therapeutic effects when consumed and ultimately […]

On Monday, June 25, 2018, the United States Food and Drug Administration announced the approval of the first marijuana-based prescription medication in the US. The drug, called Epidiolex, is a plant-derived oral solution of cannabidiol (CBD). CBD, a chemical derived from cannabis, is a cannabinoid that does not produce psychoactive effects when consumed.Produced by UK-based […]

Cannabinoids have been receiving more and more attention in the news lately and you may find yourself wondering: what is the endocannabinoid system and what role does it play in the human body? In this series of blog posts, we will explore the endocannabinoid system and how it works to keep the human body in […]

For years it seems the pharma industry has been an easy target in the court of public opinion for the high price of drugs. Few acknowledge the industry’s development costs and the financial risks it takes to study new drugs. According to the most recent Tufts report, the estimated cost of bringing a new drug […]

At CURE, we’ve been kicking off the new year in a big way! Along with a new image and freshly launched website, we’re investing heavily in product research and development and have been actively participating in industry events. One of those events took place In early January, when CURE was invited to be a presenting […]

We’re all aware of the evolving law as it relates to pharmaceutical cannabis (and cannabis in general). In the US, some states offer it; others don’t. Though it’s still against Federal law to buy or sell it, generally speaking cannabis is now more accessible to more people in a variety of forms. But many people […]